News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
138,368 Results
Type
Article (4729)
Company Profile (8)
Press Release (133631)
Multimedia
Podcasts (10)
Webinars (2)
Section
Business (49016)
Career Advice (155)
Deals (8634)
Drug Delivery (15)
Drug Development (17306)
Employer Resources (11)
FDA (3085)
Job Trends (3280)
News (71245)
Policy (5625)
Tag
2027 Biotech Bay Standard (1)
2027 Biotech Beach Standard (1)
2027 Genetown Standard (1)
Academia (370)
Accelerated approval (25)
ADA (9)
Adcomms (1)
Allergies (28)
Alliances (6201)
ALS (63)
Alzheimer's disease (435)
Antibody-drug conjugate (ADC) (196)
Approvals (3425)
Artificial intelligence (165)
ASCO (140)
Autoimmune disease (88)
Automation (20)
Bankruptcy (69)
Belgium (14)
Best Places to Work (2954)
BIO (5)
Biologics (21)
BIOSECURE Act (3)
Biosimilars (28)
BioSpace Insights (7)
Biotechnology (8)
Bispecific (6)
Bladder cancer (67)
Brain cancer (31)
Breast cancer (266)
Cancer (2104)
Cardiovascular disease (149)
Career advice (138)
Career pathing (4)
CAR-T (79)
CDC (8)
CDMO (24)
Cell therapy (212)
Cervical cancer (20)
Clinical research (16864)
Collaboration (430)
Commercialization (13)
Company closure (4)
Compensation (240)
Complete response letters (20)
COVID-19 (512)
CRISPR (19)
C-suite (210)
Cystic fibrosis (25)
Data (3333)
Decentralized trials (1)
Denatured (3)
Depression (85)
Dermatology (75)
Diabetes (174)
Diagnostics (1686)
Digital health (18)
Diversity, equity & inclusion (2)
Drug discovery (64)
Drug pricing (11)
Drug shortages (4)
Duchenne muscular dystrophy (62)
Earnings (34423)
Editorial (9)
Employer branding (3)
Employer resources (11)
ESMO (186)
Events (21186)
Executive appointments (180)
Eye disease (4)
FDA (4538)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (5)
Frontotemporal dementia (15)
Funding (299)
Gene editing (47)
Generative AI (7)
Gene therapy (138)
GLP-1 (248)
Government (705)
Grass and pollen (3)
Guidances (315)
Healthcare (3870)
Hematology (58)
HIV (25)
Huntington's disease (17)
Idiopathic pulmonary fibrosis (3)
IgA nephropathy (19)
Immunology and inflammation (55)
Immuno-oncology (22)
Indications (80)
Infectious disease (625)
Inflammatory bowel disease (61)
Influenza (45)
Intellectual property (78)
Interviews (19)
IPO (5647)
IRA (3)
Job creations (436)
Job search strategy (123)
JPM (8)
Kidney cancer (10)
Kidney disease (47)
Labor market (31)
Layoffs (85)
Leadership (5)
Legal (1023)
Licensing (16)
Liver cancer (24)
Longevity (15)
Lung cancer (325)
Lung diease (6)
Lymphoma (157)
Machine learning (12)
Management (4)
Manufacturing (224)
Marketing (11)
MASH (70)
Medical affairs (3)
Medical device (3313)
Medtech (3375)
Mergers & acquisitions (3384)
Metabolic disorders (414)
mRNA (42)
Multiple sclerosis (56)
NASH (9)
Netherlands (10)
Neurodegenerative disease (141)
Neuropsychiatric disorders (26)
Neuroscience (912)
NextGen: Class of 2026 (969)
Non-profit (742)
Now hiring (7)
Obesity (166)
Opinion (26)
Ovarian cancer (87)
Pain (73)
Pancreatic cancer (124)
Parkinson's disease (97)
Partnered (2)
Patents (146)
Patient advocacy (1)
Patient recruitment (142)
Patient selection (17)
Peanut (10)
People (6720)
Peptides (9)
Pharmaceutical (3)
Pharmacy benefit managers (5)
Phase 1 (4606)
Phase 2 (7264)
Phase 3 (6423)
Pipeline (4886)
Policy (28)
Postmarket research (520)
Preclinical (1560)
Press Release (8)
Prostate cancer (102)
Psychedelics (6)
Radiopharmaceuticals (76)
Rare diseases (285)
Real estate (740)
Recruiting (5)
Regenerative medicine (3)
Regulatory (5487)
Reports (13)
Research institute (296)
Resumes & cover letters (11)
Rett syndrome (14)
RNA editing (3)
RSV (26)
Schizophrenia (63)
Series A (50)
Series B (36)
Sickle cell disease (23)
Special edition (12)
Spinal muscular atrophy (57)
Sponsored (8)
Startups (366)
Stem cells (3)
Stomach cancer (2)
Substance use disorders (5)
Supply chain (24)
Switzerland (5)
Tariffs (15)
The Weekly (7)
Vaccines (258)
Venture capital (25)
Weight loss (103)
Women's health (31)
Worklife (2)
Date
Today (38)
Last 7 days (176)
Last 30 days (795)
Last 365 days (8066)
2026 (6844)
2025 (7909)
2024 (8979)
2023 (9960)
2022 (11326)
2021 (12431)
2020 (11443)
2019 (9393)
2018 (6285)
2017 (6289)
2016 (5142)
2015 (6412)
2014 (4436)
2013 (3238)
2012 (3708)
2011 (4048)
2010 (3603)
Location
Africa (89)
Alabama (9)
Arizona (95)
Arkansas (1)
Asia (8320)
Australia (1406)
California (4415)
Canada (952)
China (422)
Colorado (250)
Connecticut (252)
Delaware (211)
Europe (18480)
Florida (743)
Georgia (118)
Hawaii (1)
Idaho (7)
Illinois (340)
India (22)
Indiana (250)
Iowa (1)
Japan (206)
Kansas (72)
Kentucky (11)
Louisiana (20)
Maine (36)
Maryland (540)
Massachusetts (2612)
Michigan (107)
Minnesota (181)
Missouri (40)
Montana (7)
Nebraska (4)
Nevada (39)
New Hampshire (24)
New Jersey (1325)
New Mexico (8)
New York (1053)
North Carolina (395)
North Dakota (2)
Northern California (2429)
Ohio (126)
Oklahoma (2)
Oregon (4)
Pennsylvania (882)
Puerto Rico (5)
Rhode Island (6)
South America (179)
South Carolina (14)
Southern California (1700)
Tennessee (41)
Texas (688)
United States (15022)
Utah (129)
Vermont (1)
Virginia (80)
Washington D.C. (5)
Washington State (338)
Wisconsin (25)
Wyoming (1)
138,368 Results for "21".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
McKesson Corporation Declares Quarterly Dividend - October 21, 2026
October 21, 2026
·
1 min read
Press Releases
Novo Nordisk A/S - share repurchase programme - September 21, 2026
September 21, 2026
·
2 min read
Press Releases
Helus Pharma to Host Investor Presentation on October 21, 2026
October 8, 2026
·
5 min read
Press Releases
4DMT to Host Investor Day on October 21, 2026
October 5, 2026
·
2 min read
Press Releases
Arcus Biosciences Announces Commencement of Public Offering of Common Stock - October 21, 2026
October 22, 2026
·
3 min read
Press Releases
Helus Pharma Highlights Clinical Program Advancements at Investor Presentation Held on October 21, 2026
October 21, 2026
·
11 min read
Press Releases
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026
September 28, 2026
·
1 min read
Press Releases
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program - September 21, 2026
September 21, 2026
·
2 min read
Press Releases
Integra LifeSciences to Host Third Quarter 2026 Financial Results Conference Call on October 21, 2026
October 6, 2026
·
1 min read
Press Releases
Kiniksa Pharmaceuticals to Present at Wells Fargo 21st Annual Healthcare Conference
September 6, 2026
·
1 min read
1 of 13,837
Next
